Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Protecting Babies From RSV Could Prevent Childhood Asthma
    Health

    Protecting Babies From RSV Could Prevent Childhood Asthma

    By Vlaams Instituut voor BiotechnologieJanuary 5, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Asian Toddler Boy Asthma Hospital Bed Nebulizations
    Scientists have uncovered strong evidence that infection with RSV in the first months of life can significantly raise the risk of developing childhood asthma, especially in children with a family history of allergies. Credit: Shutterstock

    Protecting babies from RSV could help prevent asthma years later.

    Researchers in Belgium from VIB and Ghent University (UGent), working alongside colleagues in Denmark, have identified strong evidence that infection with respiratory syncytial virus (RSV) during early infancy greatly increases the chances of developing asthma in childhood – particularly for children who already have a family history of asthma or allergies. The study, published in Science Immunology, points to newborn RSV protection as a potential way to significantly reduce asthma cases later in life.

    Early-life infections and asthma risk

    Asthma affects an estimated 5-15% of children across Europe. The condition can interfere with daily life, place long-term strain on families, and create substantial healthcare costs. For these reasons, preventing asthma before it begins has become a critical public health goal.

    “Childhood asthma is a complex disease with many contributing factors,” says Prof. Bart Lambrecht (VIB-UGent Center for Inflammation Research), senior author of the study. “We found that early-life RSV infection and genetic allergy risk interact in a very specific way that pushes the immune system toward asthma. The encouraging news is that this process can be prevented.”

    Bart Lambrecht and Hamida Hammad
    Senior authors Prof. Bart Lambrecht (left) and Prof. Hamida Hammad (right). Credit: © VIB

    Combining population data with laboratory research

    To better understand how RSV and inherited allergy risk interact, the scientists analyzed nationwide health registry data covering all Danish children and their parents. They paired this large-scale population data with carefully controlled laboratory experiments.

    This combined approach allowed the team to see how early viral infection and genetic predisposition reinforce each other. The results revealed that infants who experience severe RSV infections in their first months of life are more likely to develop immune responses that overreact to common allergens such as house dust mites.

    Why family history matters

    The effect of early RSV infection was far stronger in children with a family background of asthma or allergies. In these cases, allergen-specific antibodies passed from parents to newborns increased sensitivity even further, making the infant immune system more prone to exaggerated reactions.

    RSV prevention blocks harmful immune changes

    The researchers also tested what happens when newborns are protected from RSV. In experimental models, blocking RSV infection prevented the immune system changes linked to asthma development. As a result, asthma did not develop.

    “With RSV prevention now becoming widely accessible, we have an opportunity to improve long-term respiratory health, not just prevent RSV hospitalizations,” says Prof. Hamida Hammad (VIB-UGent), co-senior author. “This is not just a laboratory insight. It’s a message that should help parents choose RSV prevention with confidence.”

    Expanding access to RSV protection

    Several countries are beginning to introduce maternal vaccination during the third trimester of pregnancy, along with passive immunization of newborns using long-acting antibodies. These approaches are highly effective at preventing RSV hospitalizations. However, adoption has been uneven.

    “This is a moment where policy, science, and pediatricians can come together,” Lambrecht adds. “If preventing RSV infection also reduces asthma risk, the benefits for families and health systems could be enormous.”

    Reference: “Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early life” by Elisabeth De Leeuw, Josefine F. Justesen, Cédric Bosteels, Nincy Debeuf, Manon Vanheerswynghels, Leander Jonckheere, Caroline De Wolf, Alysia Wayenberg, Karel F.A. Van Damme, Stijn Vanhee, Manon Lesage, Kim Deswarte, Sam Dupont, Morten Dahl, Hamida Hammad and Bart N. Lambrecht, 28 November 2025, Science Immunology.
    DOI: 10.1126/sciimmunol.adz4626

    This work was supported by the European Research Council, the University of Ghent, and Research Foundation – Flanders (FWO).

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Asthma Immunology Infectious Diseases RSV Vaccine
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Real Hope for Vaccine Longevity: New Data Reveals COVID Immunity Lasts Up to 8 Months

    These Seven Different “Disease Forms” Have Been Identified in Mild COVID-19

    Critical Insight Into COVID-19 Immune Response From New Study of Serum Samples

    Long-Lived Antibodies Detected in Both Blood and Saliva of Patients With COVID-19

    SARS-CoV-2 Antibodies Provide Lasting COVID-19 Immunity

    New Insight on How to Build a Better Flu Vaccine – For Long-Lasting Immunity Against New Influenza Strains

    Generic BCG Vaccine Could Be Effective Against COVID-19

    Research Shows Exposure to Common Cold Coronaviruses Can Teach the Immune System to Recognize SARS-CoV-2

    Common Molecular Feature of Antibodies That Neutralize SARS-CoV-2 Discovered, Boosting COVID-19 Vaccine Prospects

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Scientists Warn That This Common Pet Fish Can Wreck Entire Ecosystems

    Scientists Make Breakthrough in Turning Plastic Trash Into Clean Fuel Using Sunlight

    This Popular Supplement May Interfere With Cancer Treatment, Scientists Warn

    Scientists Finally Solved One of Water’s Biggest Mysteries

    Could This New Weight-Loss Pill Disrupt the Entire Market? Here’s What You Should Know About Orforglipron

    Earth’s Crust Is Tearing Open in Africa, and It Could Form a New Ocean

    Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years

    Natural Compound Shows Powerful Potential Against Rheumatoid Arthritis

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Kratom Use Explodes in the US, With Life-Changing Consequences
    • Scientists Uncover Fatal Weakness in “Zombie Cells” Linked to Cancer
    • World-First Study Reveals Human Hearts Can Regenerate After a Heart Attack
    • Why Your Dreams Feel So Real Sometimes and So Strange Other Times
    • Scientists Debunk 100-Year-Old Belief About Brain Cells, Rewriting Textbooks
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.